Head-To-Head Comparison: COLLPLANT HOLDI/S (CLGN) and Precision Therapeutics (AIPT)

COLLPLANT HOLDI/S (NASDAQ:CLGN) and Precision Therapeutics (NASDAQ:AIPT) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, profitability, dividends, institutional ownership, valuation, analyst recommendations and earnings.

Profitability

This table compares COLLPLANT HOLDI/S and Precision Therapeutics’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
COLLPLANT HOLDI/S -435.47% -74.04% -39.88%
Precision Therapeutics -719.83% -266.54% -199.98%

Insider and Institutional Ownership

0.7% of COLLPLANT HOLDI/S shares are owned by institutional investors. Comparatively, 2.3% of Precision Therapeutics shares are owned by institutional investors. 21.2% of Precision Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for COLLPLANT HOLDI/S and Precision Therapeutics, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
COLLPLANT HOLDI/S 0 0 0 0 N/A
Precision Therapeutics 0 0 0 0 N/A

Valuation & Earnings

This table compares COLLPLANT HOLDI/S and Precision Therapeutics’ top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
COLLPLANT HOLDI/S $480,000.00 39.54 -$6.02 million ($2.26) -2.46
Precision Therapeutics $650,000.00 16.04 -$7.74 million N/A N/A

COLLPLANT HOLDI/S has higher earnings, but lower revenue than Precision Therapeutics.

Summary

COLLPLANT HOLDI/S beats Precision Therapeutics on 5 of the 8 factors compared between the two stocks.

COLLPLANT HOLDI/S Company Profile

CollPlant Holdings Ltd., a regenerative medicine company, focuses on developing and commercializing tissue repair products for three-dimensional (3D) bio-printing of tissues and organs, orthobiologics, and advanced wound care markets in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen (rhCollagen) that is produced with its proprietary plant based genetic engineering technology. The company's products include Vergenix STR, a soft tissue repair matrix intended for treatment of tendinopathy; Vergenix FG, a wound-filling flowable gel for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds; and BioInks for 3D printing of tissues and organs. CollPlant Holdings Ltd. and is headquartered in Ness Ziona, Israel.

Precision Therapeutics Company Profile

Precision Therapeutics Inc. provides various healthcare products and services primarily in the United States. The company manufactures environmentally conscious systems for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care. It offers the STREAMWAY Fluid Waste Management system that suctions surgical waste fluid from the patient using standard surgical tubing; and disposables. The company also provides contract research organization (CRO) that offers personalized medicine solutions for pharmaceutical, diagnostic, and biotech industries. Its CRO services enhance the effectiveness of cancer therapy using the power of artificial intelligence applied to diseases databases. The company markets and sells its STREAMWAY Fluid Waste Management system and procedure disposables to medical facilities through various direct sales force and independent distributors. The company was formerly known as Skyline Medical Inc. and changed its name to Precision Therapeutics Inc. in February 2018. Precision Therapeutics Inc. was founded in 2002 and is based in Eagan, Minnesota.

Receive News & Ratings for COLLPLANT HOLDI/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for COLLPLANT HOLDI/S and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit